Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TTR | P02766 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 2/20 | 0.35 |
| ▸ | PARP1 | P09874 | 7/20 | 0.35 |
| ▸ | FABP4 | P15090 | 1/20 | 0.33 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3734379 | 0.84 | DHODH (0.45) | L3MBTL1GAADHODHPARP1 | |
| SCHEMBL2942698 | 0.81 | L3MBTL1 (0.56) | L3MBTL1GAAHSD17B10TTRKDM4E | |
| SCHEMBL306771 | 0.81 | L3MBTL1 (0.56) | L3MBTL1GAAHSD17B10KDM4EHPGD | |
| SCHEMBL16134523 | 0.81 | L3MBTL1 (0.56) | L3MBTL1GAAHSD17B10KDM4EHPGD | |
| SCHEMBL989259 | 0.81 | L3MBTL1 (0.40) | L3MBTL1TTRKDM4EHPGDDHODH | |
| SCHEMBL16134527 | 0.80 | KDM4E (0.57) | L3MBTL1KDM4EHPGDDHODHPARP1 | |
| SCHEMBL7056322 | 0.80 | L3MBTL1 (0.54) | L3MBTL1GAAHSD17B10DHODHPARP1 | |
| SCHEMBL11234305 | 0.80 | PARP1 (0.53) | L3MBTL1GAAHSD17B10KDM4EDHODH | |
| SCHEMBL6675098 | 0.78 | L3MBTL1 (0.55) | L3MBTL1GAAHSD17B10DHODHPARP1 | |
| SCHEMBL16278 | 0.78 | L3MBTL1 (0.55) | L3MBTL1GAAHSD17B10DHODHPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0210952-A1 | Aqueous, alkaline, silicate-containing composition for the bleaching of cellulosic fibres in the presence of percompounds | CIBA-GEIGY AG (CH) | 1987-02-04 | — | — | EP | claimed |
| EP-0210132-A1 | Aqueous, alkaline, silicate-containing composition for the bleaching of cellulosic fibres in the presence of percompounds | CIBA-GEIGY AG (CH) | 1987-01-28 | — | — | EP | claimed |
| EP-1167358-B1 | 2-Phenylbenzimidazole sulphonic acids as UV-B filters | MERCK PATENT GMBH (DE) | 2004-09-15 | — | — | EP | disclosed |
| EP-1167359-B1 | Process for the preparation of 2-arylbenzimidazole sulphonic acids | MERCK PATENT GMBH (DE) | 2004-04-28 | — | — | EP | disclosed |
| US-6593476-B2 | Using 2-arylbenzimidazolesulfonic acid | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 2003-07-15 | — | — | US | disclosed |
| US-6440401-B1 | 2-PHENYLBENZIMIDAZOLEDI- AND TRISULFONIC ACIDS; COSMETIC FORMULATIONS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2002-08-27 | — | — | US | disclosed |
| US-20020055532-A1 | UV-B filter | MERCK PATENT GESELLSCHAFT (DE) | 2002-05-09 | — | — | US | disclosed |
| US-20020016349-A1 | UV-B filters | MERCK PATENT GESELLSCHAFT (DE) | 2002-02-07 | — | — | US | disclosed |
| US-20020013474-A1 | Process for the preparation of UV filter substances | MERCK PATENT GESELLSCHAFT | 2002-01-31 | — | — | US | disclosed |
| EP-1167359-A1 | Process for the preparation of 2-arylbenzimidazole sulphonic acids and their use as UV-filters | MERCK PATENT GmbH (DE) | 2002-01-02 | — | — | EP | disclosed |
| EP-1167358-A1 | 2-Phenylbenzimidazole sulphonic acids as UV-B filters | MERCK PATENT GmbH (DE) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055532-A1 | UV-B filter | CBR1, UQCRB, H1-0 | L3MBTL1 2838/4885GAA 2641/4885HSD17B10 1899/4885 |
| US-20020013474-A1 | Process for the preparation of UV filter substances | AOX1, CYP1A1, AOC2 | L3MBTL1 4623/4885GAA 2298/4885HSD17B10 2464/4885 |
| US-20020016349-A1 | UV-B filters | CBR1, H1-0, CYP1B1 | L3MBTL1 2777/4885GAA 2716/4885HSD17B10 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.